

Dr Annunziata (Nancy) Dattola
Dr Annunziata (Nancy) Dattola is Researcher at the Department of Dermatology, University of La Sapienza in Rome, Italy.
Her main field of interest is the diagnosis and treatment of inflammatory skin diseases. In 2013, Dr Dattola completed a 2-year fellowship at the Laboratory for Investigative Dermatology at the Rockefeller University, New York, NY. During her fellowship, she focused on psoriasis, metabolic syndrome and imaging such as positron emission tomography (PET)/computerised tomography (CT), sono-elastography, and CT angiography, in the diagnosis of patients with psoriasis. In January 2021, she completed her PhD in Biochemistry and Molecular Biology with a thesis entitled: “Results of two different biological treatments in patients with PsO and PsA, and detection of early arthritis”.
Dr Dattola’s current research includes projects on biological agents for the treatment of psoriasis, laser and cosmetology. She is also involved in numerous phase III clinical trials and is author of many papers on these topics. She completed 3 years of research at the University of Rome Tor Vergata from 2018 to 2021.
Dr Dattola is a member of the “Italian task force” for women with psoriasis, member of the Italian Society of Dermatology and Venereology (SIDeMaST), member of the European Academy of Dermatology and Venereology (EADV) and member of the local organising committee for the World Congress of Dermatology 2019 Milan, Italy.
The speakers discuss the potential comorbidities with rheumatoid arthritis and SpA, including cardiovascular disease and osteoporosis, and their impact on...
The speakers discuss the continued unmet needs of patients with inflammatory diseases of skin and joints in terms of treatment outcomes and health-related...
This session reviews the chronic inflammation and pathophysiology of HS, highlighting the association between patients with inflammatory arthritis and HS. The...
This session focuses on the pathobiological relationship between psoriasis and psoriatic arthritis (PsA), how transition from psoriasis to PsA occurs, as well as...
In this session, our speakers explore the inflammatory pathways in immune-mediated inflammatory disease in the context of the evolving treatment considerations...
Following a warm welcome by a senior UCB leader and our Summit Chairs, Plenary 1 examines how higher treatment targets can be met in patients with immune...